Bridgeway Capital Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Bridgeway Capital Management’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-148,200	Closed	-$865K	–	1456
2022 Q4	$865K	Hold	148,200	–	–	0.02%	765
2022 Q3	$993K	Hold	148,200	–	–	0.03%	741
2022 Q2	$624K	Buy	148,200 +55,000	+59%	+$232K	0.01%	831
2022 Q1	$314K	Sell	93,200 -55,000	-37%	-$185K	0.01%	1066
2021 Q4	$467K	Hold	148,200	–	–	0.01%	1000
2021 Q3	$485K	Buy	148,200 +35,100	+31%	+$115K	0.01%	1042
2021 Q2	$477K	Buy	+113,100	New	+$477K	0.01%	1077
2020 Q2	–	Sell	-57,700	Closed	-$510K	–	1424
2020 Q1	$510K	Sell	57,700 -25,000	-30%	-$221K	0.01%	757
2019 Q4	$763K	Sell	82,700 -62,400	-43%	-$576K	0.01%	808
2019 Q3	$853K	Hold	145,100	–	–	0.01%	765
2019 Q2	$1.74M	Sell	145,100 -50,500	-26%	-$606K	0.02%	581
2019 Q1	$2.36M	Sell	195,600 -20,700	-10%	-$250K	0.03%	469
2018 Q4	$2.72M	Hold	216,300	–	–	0.04%	385
2018 Q3	$3.21M	Hold	216,300	–	–	0.03%	455
2018 Q2	$3.64M	Buy	216,300 +51,300	+31%	+$863K	0.04%	406
2018 Q1	$3.78M	Sell	165,000 -2,100	-1%	-$48.1K	0.04%	366
2017 Q4	$4.32M	Buy	167,100 +125,000	+297%	+$3.23M	0.05%	332
2017 Q3	$621K	Hold	42,100	–	–	0.01%	1027
2017 Q2	$587K	Sell	42,100 -28,200	-40%	-$393K	0.01%	1035
2017 Q1	$1.2M	Buy	70,300 +42,100	+149%	+$718K	0.01%	753
2016 Q4	$290K	Hold	28,200	–	–	﹤0.01%	1226
2016 Q3	$285K	Hold	28,200	–	–	﹤0.01%	1253
2016 Q2	$317K	Sell	28,200 -15,300	-35%	-$172K	﹤0.01%	1208
2016 Q1	$594K	Sell	43,500 -200	-0.5%	-$2.73K	0.01%	970
2015 Q4	$829K	Buy	43,700 +200	+0.5%	+$3.79K	0.02%	839
2015 Q3	$817K	Hold	43,500	–	–	0.02%	820
2015 Q2	$648K	Hold	43,500	–	–	0.01%	949
2015 Q1	$659K	Hold	43,500	–	–	0.01%	979
2014 Q4	$579K	Buy	43,500 +30,000	+222%	+$399K	0.01%	989
2014 Q3	$170K	Hold	13,500	–	–	﹤0.01%	1359
2014 Q2	$136K	Buy	+13,500	New	+$136K	﹤0.01%	1377